CRISPR-Cas Gene Perturbation and Editing in Human Induced Pluripotent Stem Cells-Reference-Cited by-同舟云学术

CRISPR-Cas Gene Perturbation and Editing in Human Induced Pluripotent Stem Cells

Published:2021-10-01 Issue:5 Volume:4 Page:634-655
ISSN:2573-1599
Container-title:The CRISPR Journal
language:en
Short-container-title:The CRISPR Journal

Author:

van Essen Max¹,Riepsaame Joey²,Jacob John¹

Affiliation:

1. Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom; and University of Oxford, Oxford, United Kingdom.

2. Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Biotechnology

Link

https://www.liebertpub.com/doi/pdf/10.1089/crispr.2021.0063

Reference243 articles.

1. Toward more predictive genetic mouse models of Alzheimer's disease

2. Characterization and Authentication of Cancer Cell Lines: An Overview

3. Comparison of Established Cell Lines at Different Passages by Karyotype and Comparative Genomic Hybridization

4. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors

5. Human organoids: model systems for human biology and medicine

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PTCH1-mutant human cerebellar organoids exhibit altered neural development and recapitulate early medulloblastoma tumorigenesis;Disease Models & Mechanisms;2024-02-01

2. PTCH1mutant human cerebellar organoids are associated with altered neural development and early pathways of medulloblastoma oncogenesis;2023-05-10

3. Immortalized hippocampal astrocytes from 3xTg-AD mice, a new model to study disease-related astrocytic dysfunction: a comparative review;Neural Regeneration Research;2023

4. Comparison of different gene addition strategies to modify placental derived-mesenchymal stromal cells to produce FVIII;Frontiers in Immunology;2022-12-15

5. Messenger RNA brings gene editing a step closer to treat muscular dystrophies;Molecular Therapy - Nucleic Acids;2022-06